Athersys, Inc. (ATHX): Price and Financial Metrics


Athersys, Inc. (ATHX): $1.56

0.04 (+2.63%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ATHX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 495

in industry

ATHX POWR Grades


  • Quality is the dimension where ATHX ranks best; there it ranks ahead of 32.04% of US stocks.
  • ATHX's strongest trending metric is Momentum; it's been moving down over the last 31 weeks.
  • ATHX ranks lowest in Sentiment; there it ranks in the 10th percentile.

ATHX Stock Summary

  • For ATHX, its debt to operating expenses ratio is greater than that reported by only 0.49% of US equities we're observing.
  • ATHX's price/sales ratio is 234.42; that's higher than the P/S ratio of 97.89% of US stocks.
  • Revenue growth over the past 12 months for Athersys Inc comes in at -65.62%, a number that bests merely 4.1% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Athersys Inc are RNA, GLYC, ZYME, CRBP, and MTEM.
  • Visit ATHX's SEC page to see the company's official filings. To visit the company's web site, go to www.athersys.com.

ATHX Valuation Summary

  • ATHX's EV/EBIT ratio is -3; this is 111.24% lower than that of the median Healthcare stock.
  • ATHX's price/sales ratio has moved up 230.6 over the prior 172 months.
  • ATHX's price/sales ratio has moved up 230.6 over the prior 172 months.

Below are key valuation metrics over time for ATHX.

Stock Date P/S P/B P/E EV/EBIT
ATHX 2021-04-15 257.1 11.8 -4.7 -4.0
ATHX 2020-05-19 139.8 30.8 -12.4 -11.7
ATHX 2019-03-06 8.8 4.2 -8.1 -6.3
ATHX 2018-06-28 81.0 5.6 -7.3 -5.9
ATHX 2013-09-25 23.3 8.3 -4.4 -3.6
ATHX 2013-07-02 15.1 7.3 -4.8 -3.7

ATHX Growth Metrics

  • The 2 year price growth rate now stands at 25.24%.
  • The 5 year revenue growth rate now stands at 165.4%.
  • The year over year net cashflow from operations growth rate now stands at -59.37%.
ATHX's revenue has moved down $22,508,000 over the prior 30 months.

The table below shows ATHX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 1.44 -66.8 -89.589
2020-12-31 1.44 -61.81 -78.765
2020-09-30 0.457 -54.688 -66.482
2020-06-30 0.01 -43.214 -55.954
2020-03-31 4.188 -41.914 -47.27
2019-12-31 5.633 -35.326 -44.582

ATHX Price Target

For more insight on analysts targets of ATHX, see our ATHX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $5.25 Average Broker Recommendation 1.38 (Strong Buy)

ATHX Stock Price Chart Interactive Chart >

Price chart for ATHX

ATHX Price/Volume Stats

Current price $1.56 52-week high $3.03
Prev. close $1.52 52-week low $1.35
Day low $1.50 Volume 1,100,300
Day high $1.57 Avg. volume 2,492,290
50-day MA $1.55 Dividend yield N/A
200-day MA $1.81 Market Cap 352.96M

Athersys, Inc. (ATHX) Company Bio


Athersys, Inc. focuses on the research and development activities in the field of regenerative medicine. The company was founded in 1995 and is based in Cleveland, Ohio.


ATHX Latest News Stream


Event/Time News Detail
Loading, please wait...

ATHX Latest Social Stream


Loading social stream, please wait...

View Full ATHX Social Stream

Latest ATHX News From Around the Web

Below are the latest news stories about Athersys Inc that investors may wish to consider to help them evaluate ATHX as an investment opportunity.

Athersys to Host Second Quarter Financial Results Call

CLEVELAND, July 13, 2021--Athersys to Host Second Quarter Financial Results Call on August 9th, 2021.

Yahoo | July 13, 2021

New Publication Provides Further Clarity of MultiStem's Mechanism of Action on Modulating the Inflammatory Response in Critical Care Indications

CLEVELAND, June 30, 2021--Peer-reviewed publication provides evidence of MAPC / MultiStem mechanisms of action on the inflammatory response by promoting Treg differentiation.

Yahoo | June 30, 2021

We Think Athersys (NASDAQ:ATHX) Needs To Drive Business Growth Carefully

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...

Yahoo | June 25, 2021

Athersys (ATHX) Q1 2021 Earnings Call Transcript

Image source: The Motley Fool. Athersys (NASDAQ: ATHX)Q1 2021 Earnings CallMay 06, 2021, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day, and thank you for standing by.

Yahoo | May 7, 2021

Athersys Reports First Quarter 2021 Results

Athersys reports First Quarter 2021 financial results and will provide a corporate update today at 4:30 PM EDT.

Yahoo | May 6, 2021

Read More 'ATHX' Stories Here

ATHX Price Returns

1-mo 7.59%
3-mo -7.14%
6-mo -19.38%
1-year -40.23%
3-year -18.75%
5-year -29.73%
YTD -10.86%
2020 42.28%
2019 -14.58%
2018 -20.44%
2017 18.30%
2016 48.54%

Continue Researching ATHX

Here are a few links from around the web to help you further your research on Athersys Inc's stock as an investment opportunity:

Athersys Inc (ATHX) Stock Price | Nasdaq
Athersys Inc (ATHX) Stock Quote, History and News - Yahoo Finance
Athersys Inc (ATHX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8713 seconds.